Physician profile
Stephen E Vinge
NPI 1952422909
$141.40
in general payments reported to CMS, 2019-2025
7 companies · $29.59 in 2025
The $29.59 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.51 · 2020: $27.00 · 2023: $70.30 · 2025: $29.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $29.59 | 2025 | Auvelity |
| Idorsia Pharmaceuticals US INC | $29.26 | 2023 | Quviviq |
| Lilly USA, LLC | $23.25 | 2023 | Mounjaro |
| Inspire Medical Systems, INC. | $17.79 | 2023 | Inspire |
| Mylan Specialty L.P. | $15.00 | 2020 | |
| Irhythm Technologies, INC. | $14.51 | 2019 | |
| Novo Nordisk INC | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Vinge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.